908 Devices (MASS) Reports $16.1 Million Revenue for Q2 2026

908 Devices (MASS) announced $16.1 million in revenue for Q2 2026, representing a 23% year-over-year growth. The company indicated that more than half of its revenues came from U.S. state and local customers, highlighting ongoing needs for modernization in detection capabilities. This revenue growth is supported by increased funding at the state and local level addressing challenges from the fentanyl crisis and emerging synthetic drugs. Such consistent growth is significant for investors looking for companies with strong government demand, as it may indicate further opportunities in the public sector.